Reversion of naturally occurring high-level resistance mutations to NS3 protease inhibitors in two treatment-naive individuals infected with hepatitis C virus.

Authors :: Bagaglio S
Messina E
Uberti-Foppa C
Merli M
Torre LD
Lazzarin A
Hasson H
Morsica G
Source :: The Journal of antimicrobial chemotherapy [J Antimicrob Chemother] 2013 Jun; Vol. 68 (6), pp. 1448-50. Date of Electronic Publication: 2013 Feb 06.
Publication Year :: 2013

Subjects :: Amino Acid Substitution genetics
CD4 Lymphocyte Count
HIV Infections complications
HIV Protease Inhibitors therapeutic use
Humans
RNA, Viral blood
Antiviral Agents pharmacology
Drug Resistance, Viral genetics
HIV Protease Inhibitors pharmacology
Hepacivirus drug effects
Hepacivirus genetics
Hepatitis C drug therapy
Hepatitis C virology
Mutation genetics
Viral Nonstructural Proteins genetics

Full Text Access

Tools